Crohn's Disease and Colitis Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older
- People who have a confirmed diagnosis of Crohn's disease (CD) or ulcerative colitis (UC), based on clinical, laboratory, imaging, endoscopy, or tissue analysis results
- People who weigh 45 kg (approximately 99 pounds) or more
- People who are registered members of the French Social Security system
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose colitis has not been clearly identified as a specific type
- People who do not have a confirmed diagnosis of Crohn's disease
- Women who could become pregnant and are not using a method of contraception
- People who are pregnant or currently breastfeeding
- People covered by certain specific articles of the French Public Health Code, which relate to protected groups such as people under legal guardianship or those unable to give consent (confirm with trial site)
- People who do not have the mental or legal capacity to give their own consent to participate
- People under 18 years of age who are under the authority of a judicial or administrative decision (confirm with trial site)
- People under any form of legal protection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Adeline GERMAIN, MD, PhD, CHRU Nancy
Phone: +33383153120
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients who have lost response to biotherapies (anti-TNF, ustekinumab, vedolizumab).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.